CD160 and B-cell chronic lymphocytic leukemia: In our research, we provide a collective screening of the immune-regulatory genes expression, including BTLA, CD160, SPN, TIM-3, VISTA and TIGIT on the mRNA level, as well as a comparison for two different diseases, such as CLL and Ps.